PubMed Health⌕ Search

PubMed · 14736794

The cone dysfunction syndromes.

Abstract

The cone dystrophies comprise a heterogeneous group of disorders characterised by visual loss, abnormalities of colour vision, central scotomata, and a variable degree of nystagmus and photophobia. They may be stationary or progressive. The stationary cone dystrophies are better described as cone dysfunction syndromes since a dystrophy often describes a progressive process. These different syndromes encompass a wide range of clinical and psychophysical findings. The aim is to review current knowledge relating to the cone dysfunction syndromes, with discussion of the various phenotypes, the currently mapped genes, and genotype-phenotype relations. The cone dysfunction syndromes that will be discussed are complete and incomplete achromatopsia, oligocone trichromacy, cone monochromatism, blue cone monochromatism, and Bornholm eye disease. Disorders with a progressive cone dystrophy phenotype will not be discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Michaelides, D M Hunt, A T Moore. 2004. The cone dysfunction syndromes.. https://doi.org/10.1136/bjo.2003.027102

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An effect of luminance contrast on high-spatial-frequency tritanopia.

Luminance contrast was found to affect high-spatial-frequency tritanopia despite the S-cone coordinates of the stimuli being kept constant. This proves that a traditional account of artificial tritanopias based on the spatial resolution differences between the S-cone channel and the M- and L-cone channels is not applicable here. We suggest that the lack of spatial resolution in one of the post-receptor (rather than receptor) spatio-chromatic channels could be a cause of high-spatial-frequency tritanopia.

Color Vision Defects↗

Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.

Sildenafil citrate improves erectile function in men with erectile dysfunction (ED) by selectively inhibiting cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), which is present in all vascular tissue. Sildenafil also has a weaker inhibitory action on PDE6, located in the rod and cone photoreceptors. Modest, transient visual symptoms, typically blue tinge to vision, increased brightness of lights, and blurry vision, have been reported with sildenafil use and occur more frequently at higher doses. Visual function studies in healthy subjects and in patients with eye disease suggest that sildenafil does not affect visual acuity, visual fields, and contrast sensitivity. Transient, mild impairment of color discrimination can occur around the time of peak plasma levels. Spontaneous postmarketing reports of visual adverse events, including nonarteritic anterior ischemic optic neuropathy (NAION), have been reported during the 7 years that sildenafil has been prescribed to more than 27 million men worldwide. However, because men with ED frequently have vascular risk factors that may also put them at increased risk for NAION, a causal relationship is difficult to establish. No consistent pattern has emerged to suggest any long-term effect of sildenafil on the retina or other structures of the eye or on the ocular circulation.

Color Vision Defects↗

Simulation of color deficiency in virtual reality.

Color deficiency protanopia is simulated in a virtual home environment. A color database is created to set the corresponding relation between each color for normal vision and for protanopia. Based on this database, a second texture system is set up for the home model. The proper texture system is used according to the user's choice on the interactive menu.

Color Vision Defects↗